{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:43:50Z","timestamp":1791081830056,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11239-006-6968-4","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T13:20:48Z","timestamp":1147094448000},"page":"241-247","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of platelet function in aspirin treated patients with CAD"],"prefix":"10.1007","volume":"21","author":[{"given":"Marlene S.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Kickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladina S.","family":"Ng\u2019alla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"6968_CR1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","volume":"326","author":"V Fuster","year":"1992","unstructured":"Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326(4):242\u2013250","journal-title":"N Engl J Med"},{"issue":"3","key":"6968_CR2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0038-1651121","volume":"57","author":"E Swahn","year":"1987","unstructured":"Swahn E, Wallentin L (1987) Platelet reactivity in unstable coronary artery disease. Thromb Haemost 57(3):302\u2013305","journal-title":"Thromb Haemost"},{"issue":"5","key":"6968_CR3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0735-1097(87)80336-4","volume":"10","author":"CW Hamm","year":"1987","unstructured":"Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC (1987) Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 10(5):998\u20131006","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"6968_CR4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"E Braunwald","year":"2002","unstructured":"Braunwald E, Antman EM, Beasley JW, et al. (2002) ACC\/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction\u2013summary article: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40(7):1366\u20131374","journal-title":"J Am Coll Cardiol"},{"issue":"7329","key":"6968_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists Collaboration","year":"2002","unstructured":"Antithrombotic Trialists Collaboration. (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Bmj 324(7329):71\u201386","journal-title":"Bmj"},{"issue":"5","key":"6968_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","volume":"71","author":"KH Grotemeyer","year":"1993","unstructured":"Grotemeyer KH, Scharafinski HW, Husstedt IW (1993) Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 71(5):397\u2013403","journal-title":"Thromb Res"},{"issue":"12","key":"6968_CR7","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","volume":"25","author":"CM Helgason","year":"1994","unstructured":"Helgason CM, Bolin KM, Hoff JA, et al. (1994) Development of aspirin resistance in persons with previous ischemic stroke. Stroke 25(12):2331\u20132336","journal-title":"Stroke"},{"issue":"1","key":"6968_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1620\/tjem.207.59","volume":"207","author":"GF Hobikoglu","year":"2005","unstructured":"Hobikoglu GF, Norgaz T, Aksu H, et al. (2005) High frequency of aspirin resistance in patients with acute coronary syndrome. Tohoku J Exp Med 207(1):59\u201364","journal-title":"Tohoku J Exp Med"},{"issue":"14","key":"6968_CR9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","volume":"105","author":"JW Eikelboom","year":"2002","unstructured":"Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105(14):1650\u20131655","journal-title":"Circulation"},{"issue":"6","key":"6968_CR10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","volume":"41","author":"PA Gum","year":"2003","unstructured":"Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41(6):961\u2013965.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"6968_CR11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","volume":"43","author":"WH Chen","year":"2004","unstructured":"Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43(6):1122\u20131126","journal-title":"J Am Coll Cardiol"},{"key":"6968_CR12","first-page":"106","volume":"21","author":"SK Kundu","year":"1995","unstructured":"Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA (1995) Description of an in vitro platelet function analyzer\u2013PFA-100. Semin Thromb Hemost 21 Suppl 2:106\u2013112","journal-title":"Semin Thromb Hemost"},{"key":"6968_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1313613","volume":"21","author":"EF Mammen","year":"1995","unstructured":"Mammen EF, Alshameeri RS, Comp PC (1995) Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 21 Suppl 2:113\u2013121","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"6968_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","volume":"24","author":"EF Mammen","year":"1998","unstructured":"Mammen EF, Comp PC, Gosselin R, et al. (1998) PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 24(2):195\u2013202","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"6968_CR15","first-page":"889","volume":"5","author":"DA McGill","year":"1994","unstructured":"McGill DA, Ardlie NG (1994) Abnormal platelet reactivity in men with premature coronary heart disease. Coron Artery Dis 5(11):889\u2013900","journal-title":"Coron Artery Dis"},{"key":"6968_CR16","unstructured":"Michelson AD (2002) Platelets. 956"},{"issue":"2","key":"6968_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0735-1097(98)00601-9","volume":"33","author":"JD Folts","year":"1999","unstructured":"Folts JD, Schafer AI, Loscalzo J, Willerson JT, Muller JE (1999) A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol 33(2):295\u2013303","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6968_CR18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0049-3848(88)90199-5","volume":"50","author":"JD Folts","year":"1988","unstructured":"Folts JD, Rowe GG (1988) Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries. Thromb Res 50(4):507\u2013516","journal-title":"Thromb Res"},{"key":"6968_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4684-5829-9_33","volume":"273","author":"JD Folts","year":"1990","unstructured":"Folts JD, Gering SA, Laibly SW, Bertha BG, Bonebrake FC, Keller JW (1990) Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis. Adv Exp Med Biol 273:339\u2013358","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"6968_CR20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0735-1097(94)90586-X","volume":"23","author":"HV Anderson","year":"1994","unstructured":"Anderson HV, Kirkeeide RL, Krishnaswami A, et al. (1994) Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol 23(5):1031\u20131037","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"6968_CR21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.CIR.83.6.2122","volume":"83","author":"JD Folts","year":"1991","unstructured":"Folts JD, Stamler J, Loscalzo J (1991) Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation 83(6):2122\u20132127","journal-title":"Circulation"},{"issue":"2","key":"6968_CR22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.CIR.63.2.300","volume":"63","author":"M Sobel","year":"1981","unstructured":"Sobel M, Salzman EW, Davies GC, et al. (1981) Circulating platelet products in unstable angina pectoris. Circulation 63(2):300\u2013306","journal-title":"Circulation"},{"issue":"3 Pt 1","key":"6968_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-8703(81)90310-0","volume":"102","author":"MD Rubenstein","year":"1981","unstructured":"Rubenstein MD, Wall RT, Baim DS, Harrison DC (1981) Platelet activation in clinical coronary artery disease and spasm. Am Heart J 102(3 Pt 1):363\u2013367","journal-title":"Am Heart J"},{"issue":"3","key":"6968_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/095371000403062","volume":"11","author":"JL Francis","year":"2000","unstructured":"Francis JL (2000) Platelet dysfunction detected at high shear in patients with heart valve disease. Platelets 11(3):133\u2013136","journal-title":"Platelets"},{"issue":"11","key":"6968_CR25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000141575.92958.9C","volume":"110","author":"M Frossard","year":"2004","unstructured":"Frossard M, Fuchs I, Leitner JM, et al. (2004) Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110(11):1392\u20131397","journal-title":"Circulation"},{"issue":"3","key":"6968_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","volume":"88","author":"PA Gum","year":"2001","unstructured":"Gum PA, Kottke-Marchant K, Poggio ED, et al. (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88(3):230\u2013235","journal-title":"Am J Cardiol"},{"issue":"6","key":"6968_CR27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0735-1097(03)00921-5","volume":"42","author":"L Macchi","year":"2003","unstructured":"Macchi L, Christiaens L, Brabant S, et al. (2003) Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia\/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 42(6):1115\u20131119","journal-title":"J Am Coll Cardiol"},{"issue":"2-3","key":"6968_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(03)00008-2","volume":"108","author":"L Christiaens","year":"2002","unstructured":"Christiaens L, Macchi L, Herpin D, et al. (2002) Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease. Thromb Res 108(2\u20133):115\u2013119","journal-title":"Thromb Res"},{"issue":"1","key":"6968_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0262-1746(87)90099-0","volume":"29","author":"KC Srivastava","year":"1987","unstructured":"Srivastava KC (1987) Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets. Prostaglandins Leukot Med 29(1):79\u201384","journal-title":"Prostaglandins Leukot Med"},{"issue":"3","key":"6968_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0049-3848(86)90013-7","volume":"44","author":"ME Ring","year":"1986","unstructured":"Ring ME, Corrigan JJ, Jr., Fenster PE (1986) Effects of oral diltiazem on platelet function: alone and in combination with \u201clow dose\u201d aspirin. Thromb Res 44(3):391\u2013400","journal-title":"Thromb Res"},{"key":"6968_CR31","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/00005344-198900149-00019","volume":"14","author":"E Ambrosioni","year":"1989","unstructured":"Ambrosioni E, Borghi C. (1989) Potential use of ACE inhibitors after acute myocardial infarction. J Cardiovasc Pharmacol 14 Suppl 9:S92\u2013S4","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"6968_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02024738","volume":"9","author":"B Pfister","year":"1979","unstructured":"Pfister B, Imhof P. (1979) Influence of vasodilators used in the therapy of heart failure on platelet aggregation. Agents Actions 9(2):217\u2013219","journal-title":"Agents Actions"},{"issue":"1","key":"6968_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11239-004-0172-1","volume":"18","author":"JK Cha","year":"2004","unstructured":"Cha JK, Jeong MH, Kim JW (2004) Statin reduces the platelet P-selectin expression in atherosclerotic ischemic stroke. J Thromb Thrombolysis 18(1):39\u201342","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"6968_CR34","doi-asserted-by":"crossref","first-page":"H19","DOI":"10.1152\/ajpcell.1982.242.1.C19","volume":"242","author":"ES Barnathan","year":"1982","unstructured":"Barnathan ES, Addonizio VP, Shattil SJ (1982) Interaction of verapamil with human platelet alpha-adrenergic receptors. Am J Physiol 242(1):H19\u201323","journal-title":"Am J Physiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-6968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-6968-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-6968-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:32Z","timestamp":1559386892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-6968-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["6968"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-6968-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}